Anthera Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Anthera Pharmaceuticals ( ANTH) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. This stock is trading up 11% at $2.20 in recent trading.

Today's Range: $2.21-$2.74

52-Week Range: $1.86-$9.08

Volume: 2 million

Three-Month Average Volume: 440,060

>>7 Hot Stocks on Traders' Radars

From a technical perspective, ANTH is gapping notably higher today on monster volume. This move has briefly pushed the stock into breakout territory after it crossed some near-term overhead resistance at $2.22. At last check, ANTH hit an intraday high of $2.75 but has now pulled back to around $2.20.

Traders should consider long-biased trades as long as ANTH is trending above $2.22 with strong upside volume flows. I would also consider long-biased trades if ANTH can manage to close back near its daily highs. This stock should be avoided from the long side if it closes below yesterday's low of $1.97.

If you liked this article you might like

SEC Takes On Ironridge Global Partners Over Deals Based on Buying Microcap Bills From Creditors

A Few Tricks and Treats

A Few Tricks and Treats

Why NewLead Holdings (NEWL) Stock Is Tanking In After-Hours Trading On Wednesday

Why NewLead (NEWL) Stock Is Soaring Today

NewLead Holdings (NEWL) Stock Continues to Plunge (Update)